{{Rsnum
|rsid=4636294
|Chromosome=9
|position=21747804
|Orientation=plus
|GMAF=0.3751
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 24.8 | 51.3 | 23.9
| HCB | 11.7 | 35.0 | 53.3
| JPT | 29.2 | 48.7 | 22.1
| YRI | 2.0 | 25.2 | 72.8
| ASW | 3.5 | 38.6 | 57.9
| CHB | 11.7 | 35.0 | 53.3
| CHD | 11.0 | 32.1 | 56.9
| GIH | 43.6 | 41.6 | 14.9
| LWK | 1.8 | 23.6 | 74.5
| MEX | 10.3 | 51.7 | 37.9
| MKK | 3.8 | 22.4 | 73.7
| TSI | 32.4 | 49.0 | 18.6
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=19578365
|Trait=Cutaneous nevi
|Title=Genome-wide association study identifies variants at 9p21 and 22q13 associated with development of cutaneous nevi
|RiskAllele=A
|Pval=3E-15
|OR=0.20
|ORtxt=[0.13-0.27] increase in log nevus count
|OA=1
}}

{{omim
|id=155601
|rsnum=4636294
}}

{{omim
|id=162900
|rsnum=4636294
}}

{{PMID|19578364|OA=1
}} Genome-wide association study identifies three loci associated with melanoma risk.

{{PMID|19686382|OA=1
}} Genome-wide associations studies for melanoma and nevi.

{{GET Evidence
|impact=pathogenic
|qualified_impact=Insufficiently evaluated pathogenic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs4636294
|overall_frequency_n=90
|overall_frequency_d=128
|overall_frequency=0.703125
|n_genomes=50
|n_genomes_annotated=0
|n_haplomes=82
|n_articles=0
|n_articles_annotated=0
|in_gwas=Y
|autoscore=1
|webscore=N
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}